SCHEMBL6965185

SCHEMBL6965185

O=C(CCN1CCN(CC(O)Cn2cnc3ccccc32)CC1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
LMNA P02545 1/20 0.52
AGER Q15109 5/20 0.50
HTR1A P08908 2/20 0.50
PLK1 P53350 1/20 0.50
DRD2 P14416 1/20 0.49
DRD4 P21917 1/20 0.49
DRD3 P35462 1/20 0.49
POLB P06746 1/20 0.49
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.49
HSD17B10 Q99714 1/20 0.49
APAF1 O14727 1/20 0.49
EGLN3 Q9H6Z9 1/20 0.49
P2RX7 Q99572 1/20 0.48
ALDH1A1 P00352 2/20 0.48
KMT2A Q03164 2/20 0.48
PRMT5 O14744 2/20 0.48
WDR77 Q9BQA1 2/20 0.48
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6846755 0.92 MAPT (0.51) MAPTLMNAAGERHTR1ADRD2
SCHEMBL6839062 0.86 DRD2 (0.53) MAPTLMNAHTR1ADRD2DRD4
SCHEMBL6844223 0.83 AGER (0.55) MAPTLMNAAGERDRD2DRD4
SCHEMBL6843574 0.82 HTT (0.59) MAPTLMNAAGERDRD2DRD4
SCHEMBL6839346 0.81 P2RX7 (0.56) MAPTLMNAAGERDRD2DRD4
SCHEMBL6960020 0.80 AGER (0.55) MAPTLMNAAGERDRD2DRD4
SCHEMBL6844242 0.79 LMNA (0.60) MAPTLMNAAGERPOLBTSHR
SCHEMBL6846881 0.79 DRD2 (0.64) MAPTAGERDRD2DRD4DRD3
SCHEMBL6839525 0.78 P2RX7 (0.69) MAPTLMNAAGERHTR1ADRD2
SCHEMBL8340692 0.78 AGER (0.60) MAPTLMNAAGERPOLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0775118-B1 BENZIMIDAZOLE DERIVATIVES HAVING DOPAMINERGIC ACTIVITY PFIZER (US) 2003-06-04 EP claimed
EP-0775118-B1 BENZIMIDAZOLE DERIVATIVES HAVING DOPAMINERGIC ACTIVITY PFIZER (US) 2003-06-04 EP disclosed
US-5889010-A PSYCHOLOGICAL DISORDERS; UROGENITAL DISORDERS; COGNITION ACTIVATORS; NERVOUS SYSTEM DISORDERS; VISION DEFECTS; CONGESTIVE HEART FAILURE; DRUG ABRUSE; PARKINSON'S DISEASE;ANTIINFLAMMATORY AGENTS; ANTIALLERGENS PFIZER INC. (US) 1999-03-30 US disclosed